WEST PHARMACEUTICAL SERVICES, INC. Deferred Revenue Recognized
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Deferred Revenue Recognized of $33.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $23.10M, a 26.23% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $18.30M, a 18.06% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $15.50M, a 27.23% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $21.30M, a 119.59% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for fiscal 2025 was $44.00M, a 16.71% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $37.70M, a 0.80% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $37.40M, a 33.57% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $28.00M.
| Period end | Contract with Customer, Liability, Revenue Recognized | Contract with Customer, Liability, Revenue Recognized as first filed | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33.00M 10-Q · filed 2026-07-23 | |||||
| 2026-03-31 | $23.10M 10-Q · filed 2026-04-23 | |||||
| 2025-12-31 | $44.00M 10-K · filed 2026-02-17 | |||||
| 2025-09-30 | $39.30M 10-Q · filed 2025-10-23 | |||||
| 2025-06-30 | $29.10M 10-Q · filed 2025-07-24 | |||||
| 2025-03-31 | $18.30M 10-Q · filed 2025-04-24 | |||||
| 2024-12-31 | $37.70M 10-K · filed 2025-02-18 | |||||
| 2024-09-30 | $32.80M 10-Q · filed 2024-10-24 | |||||
| 2024-06-30 | $24.20M 10-Q · filed 2024-07-25 | |||||
| 2024-03-31 | $15.50M 10-Q · filed 2024-04-25 | |||||
| 2023-12-31 | $37.40M 10-K · filed 2024-02-20 | |||||
| 2023-09-30 | $33.20M 10-Q · filed 2023-10-26 | |||||
| 2023-06-30 | $27.40M 10-Q · filed 2023-07-27 | |||||
| 2023-03-31 | $21.30M 10-Q · filed 2023-04-27 | |||||
| 2022-12-31 | $28.00M 10-K · filed 2023-02-21 | |||||
| 2022-09-30 | $23.60M 10-Q · filed 2022-10-27 | |||||
| 2022-06-30 | $17.50M 10-Q · filed 2022-07-28 | |||||
| 2022-03-31 | $9.70M 10-Q · filed 2022-04-28 | |||||
| 2021-09-30 | $30.00M 10-Q · filed 2021-10-28 | |||||
| 2021-06-30 | $28.40M 10-Q · filed 2021-07-30 | |||||
| 2021-03-31 | $17.40M 10-Q · filed 2021-04-30 | |||||
| 2020-09-30 | $23.00M 10-Q · filed 2020-10-23 | |||||
| 2020-06-30 | $19.80M 10-Q · filed 2020-07-24 | |||||
| 2020-03-31 | $10.20M 10-Q · filed 2020-04-24 | |||||
| 2019-12-31 | $110.40M 10-K · filed 2020-02-24 | |||||
| 2019-09-30 | $79.30M 10-Q · filed 2019-10-29 | |||||
| 2019-06-30 | $53.40M 10-Q · filed 2019-07-29 | |||||
| 2019-03-31 | $25.80M 10-Q · filed 2019-05-08 | |||||
| 2019-01-01 | $20.80M 10-K · filed 2020-02-24 | $11.10M 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $111.10M 10-K · filed 2019-02-28 | |||||
| 2018-09-30 | $67.00M 10-Q · filed 2018-10-30 | |||||
| 2018-06-30 | $48.40M 10-Q · filed 2018-07-31 | |||||
| 2018-03-31 | $33.90M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |